Matching trials
1,853 results
- LDP0114Independent statistical analysis of Clinical Trial of Efficacy and Safety of Levopront® 30 mg/5 ml in Patients With Dry Cough: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LEADER7Independent statistical analysis of Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LEAP-001Independent statistical analysis of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- LEAPSIndependent statistical analysis of Locomotor Experience Applied Post Stroke Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00243919).
- Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001): Complete Statistical AnalysisIndependent statistical analysis of Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001): primary endpoint results, effect estimate with…
- Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy: Complete Statistical AnalysisIndependent statistical analysis of Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- LEVO-CTSIndependent statistical analysis of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids: Complete Statistical AnalysisIndependent statistical analysis of LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- LIBERTY ASTHMA QUESTAn independent statistical analysis of the phase 3 LIBERTY ASTHMA QUEST trial of dupilumab 200 mg and 300 mg every two weeks versus matched placebo in persistent asthma, covering negative binomial rate…
- LIDSIndependent statistical analysis of A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- LIFEStatistical analysis and educational interpretation of the LIFE phase 3 trial of losartan versus atenolol in hypertension and left ventricular hypertrophy, including trial design, the composite cardiovascular endpoint, and planned statistical analysis.
- LIFEComplete statistical analysis of the LIFE Study, a randomized phase 3 trial comparing a physical activity intervention with successful aging in older adults at risk of disability, including the primary mobility-disability endpoint,…
- LIMMITLESSIndependent statistical analysis of A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ): primary endpoint results, effect estimate with…
- Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone: Complete Statistical AnalysisIndependent statistical analysis of Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Liraglutide in Adolescents With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Liraglutide in Adolescents With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02516657).
- LixiBITIndependent statistical analysis of Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study: Complete Statistical AnalysisIndependent statistical analysis of Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study: primary endpoint results, effect estimate…
- Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia: Complete Statistical AnalysisIndependent statistical analysis of Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer: Complete Statistical AnalysisIndependent statistical analysis of Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563): Complete Statistical AnalysisIndependent statistical analysis of Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome): Complete Statistical AnalysisIndependent statistical analysis of Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials – ECZTEND: Complete Statistical AnalysisIndependent statistical analysis of Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.: primary endpoint results, effect estimate with confidence…
- Long-Term Immune Persistence of GSK Biologicals’ Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule: primary endpoint results, effect estimate with confidence interval, sample-size…
- Long-term Open-Label Safety Study to Evaluate EN3409: Complete Statistical AnalysisIndependent statistical analysis of Long-term Open-Label Safety Study to Evaluate EN3409: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01755546).
- Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy: Complete Statistical AnalysisIndependent statistical analysis of Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy: primary endpoint results, effect estimate with confidence interval, sample-size…
- Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238): Complete Statistical AnalysisIndependent statistical analysis of Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238): primary endpoint results, effect estimate with confidence interval,…
- Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients: Complete Statistical AnalysisIndependent statistical analysis of Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.: Complete Statistical AnalysisIndependent statistical analysis of Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LOVSA statistical analysis and educational interpretation of the LOVS phase 3 randomized trial evaluating lung open ventilation strategies in acute respiratory distress syndrome.
- Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- LUCENT 2Independent statistical analysis of A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LUME-Lung 1Complete statistical analysis of LUME-Lung 1, the phase 3 randomized trial of BIBF 1120 plus docetaxel versus placebo plus docetaxel in second-line non-small cell lung cancer, including time-to-event, response, disease-control, quality-of-life, and…
- LUME-Lung 2Independent statistical analysis of LUME-Lung 2, a randomized phase 3 trial of nintedanib plus pemetrexed versus placebo plus pemetrexed in second-line nonsquamous non-small-cell lung cancer, including progression-free survival, overall survival, response, disease…
- Lung Health StudyIndependent statistical analysis of the Lung Health Study (NCT06290869), a randomized phase 3 study evaluating phone-based tobacco treatment, nicotine replacement, stepped care, and e-referral to the tobacco quitline for smoking cessation.
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer: primary endpoint results, effect estimate with confidence…
- LUX-Lung 6Independent statistical analysis of LUX-Lung 6, the randomized phase 3 trial comparing afatinib with gemcitabine-cisplatin chemotherapy in first-line non-small cell lung cancer. Includes progression-free survival, response, overall survival, quality-of-life endpoints, statistical methods,…
- LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05780268).
- M-F0434Independent statistical analysis of Neuropathic Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01263132).
- MA.17Independent statistical analysis of MA.17, a randomized phase 3 trial evaluating letrozole versus placebo in women with breast cancer who had received 5 years of aromatase inhibitor therapy, including disease-free survival, overall…